CHOI YOUN WOONG,최연웅,JANG JAE SANG,장재상,LEE NAM SONG,이남송,JUN HYUNG JOON,전형준
申请号:
KR1020180069955
公开号:
KR1020190142809A
申请日:
2018.06.19
申请国别(地区):
KR
年份:
2019
代理人:
摘要:
The present invention relates to a sustained-release complex preparation containing a statin-based drug, which is a HMG-CoA reductase inhibitor, and cilostazol as active components. The sustained-release complex preparation consists of a HMG-CoA reductase inhibitor-mixing part containing the HMG-CoA reductase inhibitor, and a cilostazol mixing part containing cilostazol. The cilostazol mixing part comprises rapid-release granules and sustained-release granules, exhibits quick pharmacological activity and less side effects, and also has sustained-release properties exhibiting a sufficient pharmacological effect by oral administration once a day.본 발명은 유효성분으로 HMG-CoA 환원효소 저해제인 스타틴 계열 약물과 실로스타졸을 함유하는 서방성 복합제제에 관한 것으로, HMG-CoA 환원효소 저해제를 함유하는 HMG-CoA 환원효소 저해제 혼합부, 실로스타졸을 함유하는 실로스타졸 혼합부로 이루어지며, 상기 실로스타졸 혼합부는 속방성 과립과 서방성과립을 포함하여, 빠른 약리활성을 보이면서도 부작용이 적고, 1일 1회 경구 투여만으로 충분한 약리 효과를 보이는 서방성을 가진다.